<DOC>
	<DOCNO>NCT00562614</DOCNO>
	<brief_summary>The purpose determine effect SLx-2101 dose 5mg 10mg 14 day systolic , diastolic pressure heart rate patient hypertension .</brief_summary>
	<brief_title>Safety Effect Oral Doses 5mg 10mg SLx-2101 14 Days Patients With Hypertension</brief_title>
	<detailed_description>1 . Placebo-corrected supine peripheral systolic , diastolic blood pressure heart rate 2 . 24 hour ambulatory blood pressure heart rate 3 . Safety tolerability</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male female subject 18 70 year old , inclusive Moderate severe hypertension Body weight within body mass index 1832kg/m2 The subject receive three antihypertensive agent A history drug abuse Exposure new chemical entity within 3 month prior first day dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>